Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Rotavirus infections and vaccines: burden of illness and potential impact of vaccination.

Grimwood K, Lambert SB, Milne RJ.

Paediatr Drugs. 2010 Aug 1;12(4):235-56. doi: 10.2165/11537200-000000000-00000. Review.

PMID:
20593908
2.

Cost-effectiveness and potential impact of rotavirus vaccination in the United States.

Widdowson MA, Meltzer MI, Zhang X, Bresee JS, Parashar UD, Glass RI.

Pediatrics. 2007 Apr;119(4):684-97.

PMID:
17403839
3.

Cost-Effectiveness of Monovalent Rotavirus Vaccination of Infants in Malawi: A Postintroduction Analysis Using Individual Patient-Level Costing Data.

Bar-Zeev N, Tate JE, Pecenka C, Chikafa J, Mvula H, Wachepa R, Mwansambo C, Mhango T, Chirwa G, Crampin AC, Parashar UD, Costello A, Heyderman RS, French N, Atherly D, Cunliffe NA; VACSURV Consortium.

Clin Infect Dis. 2016 May 1;62 Suppl 2:S220-8. doi: 10.1093/cid/civ1025.

4.

Rotavirus vaccines and vaccination in Latin America.

Linhares AC, Bresee JS.

Rev Panam Salud Publica. 2000 Nov;8(5):305-31. Review.

PMID:
11190969
5.

Cost-effectiveness analysis of a rotavirus immunization program for the United States.

Tucker AW, Haddix AC, Bresee JS, Holman RC, Parashar UD, Glass RI.

JAMA. 1998 May 6;279(17):1371-6.

PMID:
9582045
6.

Cost effectiveness of a pentavalent rotavirus vaccine in Oman.

Al Awaidy ST, Gebremeskel BG, Al Obeidani I, Al Baqlani S, Haddadin W, O'Brien MA.

BMC Infect Dis. 2014 Jun 17;14:334. doi: 10.1186/1471-2334-14-334.

7.

Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs.

Patel MM, Parashar UD.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S291-9. doi: 10.1086/605059. Review.

PMID:
19817612
8.

Cost-effectiveness of a new rotavirus vaccination program in Pakistan: a decision tree model.

Patel HD, Roberts ET, Constenla DO.

Vaccine. 2013 Dec 9;31(51):6072-8. doi: 10.1016/j.vaccine.2013.10.022. Epub 2013 Oct 29.

9.

Update on Rotarix: an oral human rotavirus vaccine.

O'Ryan M, Linhares AC.

Expert Rev Vaccines. 2009 Dec;8(12):1627-41. doi: 10.1586/erv.09.136. Review.

PMID:
19943758
10.

Cost-effectiveness of introducing a rotavirus vaccine in developing countries: the case of Mexico.

Valencia-Mendoza A, Bertozzi SM, Gutierrez JP, Itzler R.

BMC Infect Dis. 2008 Jul 29;8:103. doi: 10.1186/1471-2334-8-103.

11.

First rotavirus vaccine licensed: is there really a need?

Glass RI, Bresee JS, Parashar UD, Holman RC, Gentsch JR.

Acta Paediatr Suppl. 1999 Jan;88(426):2-8. Review.

PMID:
10088904
12.

Cost-effectiveness of a pentavalent human-bovine reassortant rotavirus vaccine for children ≤5 years of age in Taiwan.

Itzler RF, Chen PY, Lac C, El Khoury AC, Cook JR.

J Med Econ. 2011;14(6):748-58. doi: 10.3111/13696998.2011.614303. Epub 2011 Sep 15.

PMID:
21919673
13.

Rotavirus vaccines against diarrhoeal disease.

Vesikari T.

Lancet. 1997 Nov 22;350(9090):1538-41. Review.

PMID:
9388411
14.

Population effectiveness of the pentavalent and monovalent rotavirus vaccines: a systematic review and meta-analysis of observational studies.

Hungerford D, Smith K, Tucker A, Iturriza-Gómara M, Vivancos R, McLeonard C, A Cunliffe N, French N.

BMC Infect Dis. 2017 Aug 15;17(1):569. doi: 10.1186/s12879-017-2613-4.

15.

Epidemiological and Economic Impact of Monovalent and Pentavalent Rotavirus Vaccines in Low and Middle Income Countries: A Cost-effectiveness Modeling Analysis.

Paternina-Caicedo A, De la Hoz-Restrepo F, Alvis-Guzmán N.

Pediatr Infect Dis J. 2015 Jul;34(7):e176-84. doi: 10.1097/INF.0000000000000727.

PMID:
25923424
16.

Post-licensure experience with rotavirus vaccination in high and middle income countries; 2006 to 2011.

Lopman BA, Payne DC, Tate JE, Patel MM, Cortese MM, Parashar UD.

Curr Opin Virol. 2012 Aug;2(4):434-42. doi: 10.1016/j.coviro.2012.05.002. Epub 2012 Jun 29. Review.

PMID:
22749491
17.

Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries.

Tu HA, Rozenbaum MH, Coyte PC, Li SC, Woerdenbag HJ, Postma MJ.

Vaccine. 2012 Feb 14;30(8):1521-8. doi: 10.1016/j.vaccine.2011.11.052. Epub 2011 Nov 23.

PMID:
22119590
18.

Projected cost-effectiveness of rotavirus vaccination for children in Asia.

Podewils LJ, Antil L, Hummelman E, Bresee J, Parashar UD, Rheingans R.

J Infect Dis. 2005 Sep 1;192 Suppl 1:S133-45.

PMID:
16088797
19.

Cost-effectiveness analysis of rotavirus vaccination in Argentina.

Urueña A, Pippo T, Betelu MS, Virgilio F, Hernández L, Giglio N, Gentile Á, Diosque M, Vizzotti C.

Vaccine. 2015 May 7;33 Suppl 1:A126-34. doi: 10.1016/j.vaccine.2014.12.074.

PMID:
25919152
20.

Rotavirus vaccines: development and use for the prevention of diarrhoeal disease.

Vesikari T.

Ann Med. 1999 Feb;31(1):79-85. Review.

PMID:
10219717

Supplemental Content

Support Center